These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 15977763)
1. When a drug is withdrawn. Johnson LJ Med Econ; 2005 May; 82(10):68. PubMed ID: 15977763 [No Abstract] [Full Text] [Related]
2. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval. O'Reilly JT Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397 [No Abstract] [Full Text] [Related]
3. Legal overprotection. Friedman JH Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378 [No Abstract] [Full Text] [Related]
4. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases. Shea LL; Hanson A; Guglielmetti TM; Levy K Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388 [No Abstract] [Full Text] [Related]
5. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say. DerGurahian J Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373 [No Abstract] [Full Text] [Related]
6. The preemptive scope of the Medical Device Amendments of 1976. Sunshine PH Food Drug Law J; 1995; 50(1):191-212. PubMed ID: 10342991 [No Abstract] [Full Text] [Related]
7. Ensuring the safety of genotech drugs through implied warranty theory. Serra WM Am J Law Med; 1997; 23(2-3):363-81. PubMed ID: 9262761 [No Abstract] [Full Text] [Related]
8. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule. Fed Regist; 1998 Oct; 63(195):54082-9. PubMed ID: 10185826 [TBL] [Abstract][Full Text] [Related]
9. Civil and criminal liability associated with food recalls. Packman JM Food Drug Law J; 1998; 53(3):437-52. PubMed ID: 10346721 [No Abstract] [Full Text] [Related]
10. Report hits FDA to revamp safety oversight. Finkelstein JB J Natl Cancer Inst; 2006 Jul; 98(13):884-5. PubMed ID: 16818849 [No Abstract] [Full Text] [Related]
11. The FDA and the tort system: postmarketing surveillance, compensation, and the role of litigation. Struve CT Yale J Health Policy Law Ethics; 2005; 5(2):587-669. PubMed ID: 16052895 [No Abstract] [Full Text] [Related]
12. Reforms on drug safety. Nature; 2006 Sep; 443(7110):372. PubMed ID: 17006474 [No Abstract] [Full Text] [Related]
14. Drug safety: a contrarian's point of view. Cobert B Food Drug Law J; 2007; 62(3):501-12. PubMed ID: 17915392 [No Abstract] [Full Text] [Related]
15. Serious liver injury. Leading reason for drug removals, restrictions. Meadows M FDA Consum; 2001; 35(3):8-9. PubMed ID: 11458559 [No Abstract] [Full Text] [Related]
16. Taking an alternative risk. Sveska KJ Mich Health Hosp; 1998; 34(6):26-7. PubMed ID: 10187139 [TBL] [Abstract][Full Text] [Related]
17. Medical device reports raise and red flag. Miles F; Miles JF Provider; 1997 Jan; 23(1):53, 55-6. PubMed ID: 10166155 [No Abstract] [Full Text] [Related]
18. Despite warnings, drug giant took long path to Vioxx recall. Berenson A; Harris G; Meier B; Pollack A N Y Times Web; 2004 Nov; ():A1, A32. PubMed ID: 15599982 [No Abstract] [Full Text] [Related]
19. Drug-review deadlines and safety problems. Nardinelli C; Lanthier M; Temple R N Engl J Med; 2008 Jul; 359(1):95-6; author reply 96-8. PubMed ID: 18596282 [No Abstract] [Full Text] [Related]
20. Medical device recalls from 2004 to 2006: a focus on Class I recalls. Villarraga ML; Guerin HL; Lam T Food Drug Law J; 2007; 62(3):581-92. PubMed ID: 17915400 [No Abstract] [Full Text] [Related] [Next] [New Search]